FIELD: ophthalmology.
SUBSTANCE: invention is a medicine representing the exciter of neurite genesis of eye tissue, use of the stimulator and method of neurite genesis stimulation. The medicine for eye tissue neurite genesis contains N-(1-acetylpiperidine-4-yl)-4-fluorbenzamide or its pharmaceutically applicable salt and medicine for neurite genesis stimulation of cornea and retina containing N-(1-acetylpiperidine-4-yl)-4-fluorbenzamide or its pharmaceutically applicable salt. The method of neurite genesis stimulation of eye tissue, retina neurite genesis includes insertion of effective quantity of N-(1-acetylpiperidine-4-yl)-4-fluorbenzamide or its pharmaceutically applicable salt into subject who in need of eye tissue neurite genesis.
EFFECT: invention allows improving sensibility of retina, improves treatment of Ocular surface disease, disease of retina epithelium, eye disfunction.
15 cl, 1 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| WATER-BASED LIQUID COMPOSITION CONTAINING AMIDE COMPOUND | 2007 |
|
RU2476219C2 |
| COMPOUNDS FOR TREATING/PREVENTING INFLAMMATORY OPHTHALMIC DISEASES | 2011 |
|
RU2582609C2 |
| GLAUCOMA TREATMENT | 2018 |
|
RU2759998C2 |
| COMPOSITIONS AND METHODS FOR INSERTION OF TUBULIN-BINDING AGENTS FOR EYE DISEASE THERAPY | 2002 |
|
RU2354398C2 |
| AGENT INHIBITING ANGIOGENESIS IN VISUAL ORGAN DISEASE | 2001 |
|
RU2177801C1 |
| COMPOSITIONS AND WAYS OF INJECTIONS OF AGENTS BINDING TUBULIN, FOR TREATMENT OF EYE DISEASES | 2004 |
|
RU2359693C2 |
| TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS | 2018 |
|
RU2815482C2 |
| VITAMIN D MICROEMULSIONS AND THEIR APPLICATIONS | 2019 |
|
RU2812079C2 |
| METHOD OF PRODUCING ORGAN CULTURE CHOROIDAL-PIGMENT COMPLEX FROM ADULT CADAVER DONOR'S EYE | 2014 |
|
RU2578526C1 |
| THERAPEUTIC AGENT (Y-39983) FOR CORNEAL ENDOTHELIAL DYSFUNCTION | 2010 |
|
RU2563141C2 |
